These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35434701)

  • 1. From Qualitative to Quantitative AOP: A Case Study of Neurodegeneration.
    Sinitsyn D; Garcia-Reyero N; Watanabe KH
    Front Toxicol; 2022; 4():838729. PubMed ID: 35434701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative AOP of mitochondrial toxicity based on data from three cell lines.
    Tebby C; Gao W; Delp J; Carta G; van der Stel W; Leist M; Jennings P; van de Water B; Bois FY
    Toxicol In Vitro; 2022 Jun; 81():105345. PubMed ID: 35278637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of an Adverse Outcome Pathway Network by Bayesian Regression and Bayesian Network Modeling.
    Moe SJ; Wolf R; Xie L; Landis WG; Kotamäki N; Tollefsen KE
    Integr Environ Assess Manag; 2021 Jan; 17(1):147-164. PubMed ID: 32965776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials.
    Martens M; Verbruggen T; Nymark P; Grafström R; Burgoon LD; Aladjov H; Torres Andón F; Evelo CT; Willighagen EL
    Front Genet; 2018; 9():661. PubMed ID: 30622555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology.
    Groh KJ; Carvalho RN; Chipman JK; Denslow ND; Halder M; Murphy CA; Roelofs D; Rolaki A; Schirmer K; Watanabe KH
    Chemosphere; 2015 Feb; 120():764-77. PubMed ID: 25439131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment.
    Perkins EJ; Ashauer R; Burgoon L; Conolly R; Landesmann B; Mackay C; Murphy CA; Pollesch N; Wheeler JR; Zupanic A; Scholz S
    Environ Toxicol Chem; 2019 Sep; 38(9):1850-1865. PubMed ID: 31127958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semantic characterization of adverse outcome pathways.
    Wang RL
    Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network.
    Spînu N; Cronin MTD; Lao J; Bal-Price A; Campia I; Enoch SJ; Madden JC; Mora Lagares L; Novič M; Pamies D; Scholz S; Villeneuve DL; Worth AP
    Comput Toxicol; 2022 Feb; 21():100206. PubMed ID: 35211661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse outcome pathways and linkages to transcriptomic effects relevant to ionizing radiation injury.
    Yu J; Tu W; Payne A; Rudyk C; Cuadros Sanchez S; Khilji S; Kumarathasan P; Subedi S; Haley B; Wong A; Anghel C; Wang Y; Chauhan V
    Int J Radiat Biol; 2022; 98(12):1789-1801. PubMed ID: 35939063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Study on Integrating a New Key Event Into an Existing Adverse Outcome Pathway on Oxidative DNA Damage: Challenges and Approaches in a Data-Rich Area.
    Huliganga E; Marchetti F; O'Brien JM; Chauhan V; Yauk CL
    Front Toxicol; 2022; 4():827328. PubMed ID: 35573276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approach.
    van Ertvelde J; Verhoeven A; Maerten A; Cooreman A; Santos Rodrigues BD; Sanz-Serrano J; Mihajlovic M; Tripodi I; Teunis M; Jover R; Luechtefeld T; Vanhaecke T; Jiang J; Vinken M
    J Biomed Inform; 2023 Sep; 145():104465. PubMed ID: 37541407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AOPERA: A proposed methodology and inventory of effective tools to link chemicals to adverse outcome pathways.
    Rycroft TE; Foran CM; Thrash A; Cegan JC; Zollinger R; Linkov I; Perkins EJ; Garcia-Reyero N
    ALTEX; 2020; 37(1):64-74. PubMed ID: 31453632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Adverse Outcome Pathway Concept to
    Jarzina S; Di Fiore S; Ellinger B; Reiser P; Frank S; Glaser M; Wu J; Taverne FJ; Kramer NI; Mally A
    Front Toxicol; 2022; 4():864441. PubMed ID: 35516525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging the Gap Between Human Toxicology and Ecotoxicology Under One Health Perspective by a Cross-Species Adverse Outcome Pathway Network for Reproductive Toxicity.
    Dufourcq Sekatcheff E; Jeong J; Choi J
    Environ Toxicol Chem; 2024 Jul; ():. PubMed ID: 38980262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a putative adverse outcome pathway network for male rat reproductive tract abnormalities with specific considerations for the androgen sensitive window of development.
    Palermo CM; Foreman JE; Wikoff DS; Lea I
    Curr Res Toxicol; 2021; 2():254-271. PubMed ID: 34401750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of neurotoxicology (NT)/developmental neurotoxicology (DNT) adverse outcome pathways and key event linkages with in vitro DNT screening assays.
    Pitzer EM; Shafer TJ; Herr DW
    Neurotoxicology; 2023 Dec; 99():184-194. PubMed ID: 37866692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case example of a radiation-relevant adverse outcome pathway to lung cancer.
    Chauhan V; Sherman S; Said Z; Yauk CL; Stainforth R
    Int J Radiat Biol; 2021; 97(1):68-84. PubMed ID: 31846388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative adverse outcome pathway (qAOP) models for toxicity prediction.
    Spinu N; Cronin MTD; Enoch SJ; Madden JC; Worth AP
    Arch Toxicol; 2020 May; 94(5):1497-1510. PubMed ID: 32424443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the quantification approach to a radiation relevant adverse outcome pathway for lung cancer.
    Stainforth R; Schuemann J; McNamara AL; Wilkins RC; Chauhan V
    Int J Radiat Biol; 2021; 97(1):85-101. PubMed ID: 32909875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a qAOP framework for predictive toxicology - Linking data to decisions.
    Paini A; Campia I; Cronin MTD; Asturiol D; Ceriani L; Exner TE; Gao W; Gomes C; Kruisselbrink J; Martens M; Meek MEB; Pamies D; Pletz J; Scholz S; Schüttler A; Spînu N; Villeneuve DL; Wittwehr C; Worth A; Luijten M
    Comput Toxicol; 2022 Feb; 21():100195. PubMed ID: 35211660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.